Identification of differentially expressed proteins in human glioblastoma cell lines and tumors

GLIA

Volumn 42, Issue 2, 2003, Pages 194-208

  Zhang, Rulin ^a   Tremblay, Tammy Lynn ^a   McDermid, Angela ^a   Thibault, Pierre ^a   Stanimirovic, Danica ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Cystatin B; Glioblastoma; Hsp27; Liquid chromatography tandem mass spectrometry (LC MS MS); Major vault protein; Matrix assisted laser desorption ionization time of flight (MALDI TOF); Proteomics; Tissue transglutaminase; U87MG

Indexed keywords

ALPHA CRYSTALLIN; BETA ACTIN; CALCYCLIN; CALPONIN; CYSTATIN B; DIHYDROPYRIMIDINASE; DIMETHYLARGININASE; ELONGATION FACTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR; EZRIN; FATTY ACID BINDING PROTEIN; GALECTIN 1; GELATINASE A; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE TRANSFERASE; GLYCINE AMIDINOTRANSFERASE; GUANINE NUCLEOTIDE BINDING PROTEIN; HEAT SHOCK PROTEIN 27; INITIATION FACTOR 5A; LAMININ; LUNG RESISTANCE PROTEIN; OSTEONECTIN; PHOSPHOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RNA; SORCIN; SUPEROXIDE DISMUTASE; UBIQUITIN; UNINDEXED DRUG;

AMINO ACID SEQUENCE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ASTROCYTES; BRAIN NEOPLASMS; CYSTATINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EPIDERMAL GROWTH FACTOR; FETUS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HEAT-SHOCK PROTEINS; HUMANS; MUTATION; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEINS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSGLUTAMINASES; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN; UP-REGULATION; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0038326942     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10222     Document Type: Article

References (47)

1. Annabi B, Pilorget A, Bousquet-Gagnon N, Gingras D, Beliveau R 2001. Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells. Biochem J 359:325-333.
2. Authier F, Métioui M, Bell AW, Mort JS. 1999. Negative regulation of epidermal growth factor signaling by selective proteolytic mechanisms in the endosome mediated by cathepsin B. J Biol Chem 274:33723-33731.
3. Bacher G, Korner R, Atrih A, Foster SJ, Roepstorff P, Allmaier G. 2001. Negative and positive ion matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and positive ion nanoelectrospray ionization quadrupole ion trap mass spectrometry of peptidoglycan fragments isolated from various Bacillus species. J Mass Spectrom 36:124-139.
4. Bagaglio DM, Cheng EH, Gorelick FS, Mitsui K, Nairn AC, Hait WN. 1993. Phosphorylation of elongation factor 2 in normal and malignant glial cells. Cancer Res 53(Suppl 10):2260-2264.
5. Benaim G, Villalobo A. 2002. Phosphorylation of calmodulin: functional implications. Eur J Biochem 269:3619-3631.
6. Camby I, Lefranc F, Titeca G, Neuci S, Fastrez M, Dedecken L, Schafer BW, Brotchi J, Heizmann CW, Pochet R, Salmon I, Kiss R, Decaestecker C. 2000. Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumours. Neuropathol Appl Neurobiol 26:76-90.
7. Caraglia M, Marra M, Giuberti G, D'Alessandro AM, Budillon A, del Prete S, Lentini A, Beninati S, Abbruzzese A. 2001. The role of eukaryotic initiation factor 5A in the control of cell proliferation and apoptosis. Amino Acids 20:91-104.
8. Chew CS, Parente JA Jr, Chen X, Chaponnier C, Cameron RS. 2000. The LIM and SH3 domain-containing protein, lasp-1, may link the cAMP signaling pathway with dynamic membrane restructuring activities in ion-transporting epithelia. J Cell Sci 113:2035-2045.
9. Choy L, Derynck R. 1998. The type II transforming growth factor (TGF)-beta receptor-interacting protein TRIP-1 acts as a modulator of the TGF-beta response. J Biol Chem 273:31455-31462.
10. Ferrington DA, Sun H, Murray KK, Costa J, Williams TD, Bigelow DJ, Squier TC. 2001. Selective degradation of oxidized calmodulin by the 20 S proteasome. J Biol Chem 276:937-943.
11. Fountoulakis M, Hardmaier R, Schuller E, Lubec G. 2000. Differences in protein level between neonatal and adult brain. Electrophoresis 21:673-678.
12. Godovac-Zimmermann J, Brown LR. 2001. Perspectives for mass spectrometry and functional proteomics. Mass Spectrom Rev 20:157.
13. Gunnersen JM, Spirkoska V, Smith PE, Danks A, Tan SS. 2000. Growth and migration markers of rat C6 glioma cells identified by serial analysis of gene expression. Glia 32:146-154.
14. Hamajima N, Matsuda K, Sakata S, Tamaki N, Sasaki K, Nonaka M. 1996. A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. Gene 180:157-163.
15. Helmbrecht K, Zeise E, Rensing L. 2000. Chaperones in cell cycle regulation and mitogenic signal transduction: a review. Cell Prolif 33:341-365.
16. Hermisson M, Strik H, Rieger J, Dichgans J, Meyermann R, Weller M. 2000. Expression and functional activity of heat shock proteins in human glioblastoma multiforme. Neurology 54:1357-1365.
17. Hilton DA, Love S, Barber R. 1997. Increased expression of transglutaminase in glioblastomas. Neuropthol Appl Neurobiol 23:507-511.
18. Hofer S, Herrmann R. 2001. Chemotherapy for malignant brain tumors of astrocytic and oligodendroglial lineage. J Cancer Res Clin Oncol 127:91-95.
19. Honore B, Vorum H. 2000. The CREC family, a novel family of multiple EF-hand, low-affinity Ca(2+)-binding proteins localised to the secretory pathway of mammalian cells. FEBS Lett 466:11-18.
20. Iwaki T, Miyazono M, Hitosumatsu T, Tateishi J. 1994. An immunohistochemical study of tissue transglutaminase in gliomas with reference to their cell dying processes. Am J Pathol 145:776-781.
21. Kachra Z, Beaulieu E, Delbecchi L, Mousseau N, Berthelet F, Moumdjian R, Del Maestro R, Béliveau R. 1999. Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Clin Exp Metastasis 17:555-566.
22. Kitamura K, Takayama M, Hamajima N, et al. 1999. Characterization of the human dihydropyrimidinase-related protein 2 (DRP-2) gene. DNA Res 6:291-297.
23. Menon PM, Gutierrez A, Rempel SA. 2000. A study of SPARC and vitronectin localization and expression in pediatric and adult gliomas: high SPARC secretion correlates with decreased migration on vitronectin. Int J Oncol 17:683-693.
24. Nagane M, Coufal F, Lin H, Bogler O, Cavenee WK, Huang HJ. 1996. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res 56:5079-5086.
25. Nagane M, Lin H, Cavenee WK, Huang HJ. 2001. Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications. Cancer Lett 162:S17-S21.
26. Nishikawa R, Ji XD, Harmon R, Lazar CS, Gill GN, Cavenee WK, Huang HJ. 1994. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity., Proc Natl Acad Sci 91:7727-7730.
27. Okuzawa K, Franzen B, Linder S, Hirano T, Berhman T, Ebihara Y, Kato H, Auer G. 1994. Characterization of gene expression in clinical lung cancer materials by two-dimensional polyacrylamide gel electrophoresis., Electrophoresis 15:382-390.
28. Paweletz CP, Liotta LA, Petricoin EF III. 2001. New technologies for biomarker analysis of prostate cancer progression: laser capture microdissection and tissue proteomics. Urology 57(4 Suppl 1):160-163.
29. Pickel VM, Clarke CL, Meuers MB. 1997. Ultrastructural localization of sorcin, a 22 kDa calcium-binding protein, in the rat caudateputamen nucleus: association with ryanodine receptors and intracellular calcium release. J Comp Neurol 386:625-634.
30. Proud CG. 1994. Peptide-chain elongation in eukaryotes. Mol Biol Rep 19:161-170.
31. Rempel SA, Golembieski WA, Ge S, Lemke N, Elisevich K, Mikkelsen T, Gutierrez JA. 1998. SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. J Neuropath Exp Neurol 57:1112-1121.
32. Ria F, Landriscina M, Remiddi F, Rosselli R, et al. 2001. The level of manganese superoxida dismutase content is an independent prognostic factor for glioblastoma: biological mechanisms and clinical implications. Br J Cancer 84:529-534.
33. Rooprai HK, McCormick D. 1997. Proteases and their inhibitors in human brain tumours: a review. Anticancer Res 17:4151-4162.
34. Sallinen S-L, Sallinen PK, Haapasalo HK, Helin HJ, Helén PT, Schraml P, Kallioniemi O-P, Kononen J. 2000. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res 60:6617-6622.
35. Sandstrom M, Johansson M, Sanstrom J, Bergenheim AT, Henriksson R. 1999. Expression of the proteolytic factors, tPA and uPA, PAI-1 and VEGF during malignant glioma progression. Int J Dev Neurosci 17:473-481.
36. Sarto C, Binz PA, Mocarelli P. 2000. Heat shock proteins in human cancer. Electrophoresis 21:1218-1226.
37. Scheffer GL, Schroeijers AB, Izquierdo MA, Wiemer EA, Scheper RJ. 2000. Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer. Curr Opin Oncol 12:550-556.
38. Schreiber V, Moog-Lutz C, Regnier CH, et al. 1998. Lasp-1, a novel type of actin-binding protein accumulating in cell membrane extensions. Mol Med 4:675-687.
39. Sehgal A. 1998. Molecular changes during the genesis of human gliomas. Semin Surg Oncol 14:3-12.
40. Sivaparvathi M, Yamamoto M, Nicolson GL, Gokaslan ZL, Fuller GN, Liotta LA, Sawaya R, Rao JS. 1996. Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas. Clin Exp Metastasis 14:27-34.
41. Strojan P, Budihna M, Smid L, Svetic B, Vrhovec I, Kos J, Skrk J. 2000. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 6:1052-1062.
42. Tian XX, Pang JC, To SS, Ng HK. 1999. Restoration of wild-type PTEN expression leads to apoptosis, induces differentiation, and reduces telomerase activity in human glioma cells. J Neuropathol Exp Neurol 58:472-479.
43. Voldborg BR, Damstrup L, Spang-Thomsen M, Poulsen HS. 1997. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann Oncol 8:1197-1206.
44. 2+-binding activity. Biochim Biophys Acta 1386:121-131.
45. Welsh MJ, Gaestel M. 1998. Small heat-shock protein family: function in health and disease. Ann NY Acad Sci 851:28-35.
46. Yang J, Yang JM, Iannone M, Shih WJ, Lin Y, Halt WN. 2001. Disruption of EF-2 kinase/Hsp90 complex: a possible mechanism to inhibit glioblastoma by geldanamycin. Cancer Res 61:4010-4016.
47. Yong VW, Tejada-Berges T, Goodyear CG, Antel JP, Yong FP. 1992. Differential proliferative responses of human and mouse astrocytes to gamma interferon. Glia 6:269-280.